Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;34:1237-1241

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vaziri, N. D.
Right arrow Articles by Wang, X. Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaziri, N. D.
Right arrow Articles by Wang, X. Q.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(D)-PENICILLAMINE
*ISOSORBIDE DINITRATE
*NITRIC OXIDE

(Hypertension. 1999;34:1237.)
© 1999 American Heart Association, Inc.


Scientific Contributions

cGMP-Mediated Negative-Feedback Regulation of Endothelial Nitric Oxide Synthase Expression by Nitric Oxide

Nosratola D. Vaziri; Xiu Q. Wang

From the Division of Nephrology, Department of Medicine, University of California, Irvine, Calif 92697.

Abstract—Earlier studies have demonstrated that nitric oxide (NO) exerts a fast-acting inhibitory influence on endothelial NO synthase (eNOS) enzymatic activity in isolated vascular tissue preparations. The present study was designed to examine the possible effect of NO on eNOS protein expression in cultured endothelial cells and intact animals. Human coronary endothelial cells were incubated with S-nitroso-N-acetyl-penicillamine (SNAP, an NO donor), oxyhemoglobin (HGB, an NO trapping agent), SNAP plus HGB, or inactive vehicle (control). In other experiments, cells were treated with 3-isobutyl-1-methylxanthine (a phosphodiesterase inhibitor), 1H-[1,2,4]oxadiazolo-[4,3–2]quinoxalin-1-one (ODQ, a guanylate cyclase inhibitor), SNAP plus ODQ, 8-bromo-cGMP (8-Br-cGMP, a cell-permeable cGMP compound), 8-Br-cGMP plus HGB, or inactive vehicle in order to discern the effect of cGMP. The incubations were conducted for 24 hours, and total nitrate plus nitrite production and eNOS protein abundance (Western analysis) were measured. To determine the effect of NO on eNOS expression in vivo, rats were treated with either the NO donor isosorbide dinitrate or placebo by gastric gavage for 48 hours, and aortic eNOS protein expression was examined. The NO donor SNAP markedly depressed, whereas the NO scavenger HGB significantly raised, eNOS protein expression. The downregulatory action of SNAP was completely abrogated by HGB. Phosphodiesterase inhibitor and 8-Br-cGMP downregulated, whereas the guanylate cyclase inhibitor ODQ upregulated eNOS protein expression. The downregulatory action of SNAP was completely overcome by the guanylate cyclase inhibitor ODQ, and the upregulatory action of the NO scavenger HGB was abrogated by 8-Br-cGMP. Administration of NO donor resulted in a marked downregulation of aortic eNOS protein expression in intact animals, thus confirming the in vitro findings. NO serves as a negative-feedback regulator of eNOS expression via a cGMP-mediated process.


Key Words: nitric oxide • cyclic GMP • nitric oxide synthase • endothelium • arteries • hemoglobin




This article has been cited by other articles:


Home page
Toxicol Ind HealthHome page
M. Sonmez, F Narin, D Akkus, and S Ozdamar
Effect of melatonin and vitamin C on expression of endothelial NOS in heart of chronic alcoholic rats
Toxicology and Industrial Health, July 1, 2009; 25(6): 385 - 393.
[Abstract] [PDF]


Home page
HypertensionHome page
S. Van Linthout, F. Spillmann, M. Lorenz, M. Meloni, F. Jacobs, M. Egorova, V. Stangl, B. De Geest, H.-P. Schultheiss, and C. Tschope
Vascular-Protective Effects of High-Density Lipoprotein Include the Downregulation of the Angiotensin II Type 1 Receptor
Hypertension, April 1, 2009; 53(4): 682 - 687.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
V. D. Ramseyer and J. L. Garvin
Angiotensin II Decreases Nitric Oxide Synthase 3 Expression via Nitric Oxide and Superoxide in the Thick Ascending Limb
Hypertension, February 1, 2009; 53(2): 313 - 318.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. D. Vaziri
Mechanisms of lead-induced hypertension and cardiovascular disease
Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H454 - H465.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Yin, J. Hoffmann, S. M. Kaestle, N. Neye, L. Wang, J. Baeurle, W. Liedtke, S. Wu, H. Kuppe, A. R. Pries, et al.
Negative-Feedback Loop Attenuates Hydrostatic Lung Edema via a cGMP-Dependent Regulation of Transient Receptor Potential Vanilloid 4
Circ. Res., April 25, 2008; 102(8): 966 - 974.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Lopez-Sepulveda, R. Jimenez, M. Romero, M. J. Zarzuelo, M. Sanchez, M. Gomez-Guzman, F. Vargas, F. O'Valle, A. Zarzuelo, F. Perez-Vizcaino, et al.
Wine Polyphenols Improve Endothelial Function in Large Vessels of Female Spontaneously Hypertensive Rats
Hypertension, April 1, 2008; 51(4): 1088 - 1095.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
Y. Dong and L. P. Thompson
Differential Expression of Endothelial Nitric Oxide Synthase in Coronary and Cardiac Tissue in Hypoxic Fetal Guinea Pig Hearts
Reproductive Sciences, October 1, 2006; 13(7): 483 - 490.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Mochizuki, P. Sipkema, M. Goto, O. Hiramatsu, H. Nakamoto, E. Toyota, T. Kajita, F. Shigeto, T. Yada, Y. Ogasawara, et al.
Exogenous NO suppresses flow-induced endothelium-derived NO production because of depletion of tetrahydrobiopterin
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H553 - H558.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Herrera and J. L. Garvin
A high-salt diet stimulates thick ascending limb eNOS expression by raising medullary osmolality and increasing release of endothelin-1
Am J Physiol Renal Physiol, January 1, 2005; 288(1): F58 - F64.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. M. Parnell, J. P. F. Chin-Dusting, J. Starr, and D. M. Kaye
In vivo and in vitro evidence for ACh-stimulated L-arginine uptake
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H395 - H400.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. D. I. Anderson, D. Rahmutula, and D. G. Gardner
Tumor Necrosis Factor-{alpha} Inhibits Endothelial Nitric-oxide Synthase Gene Promoter Activity in Bovine Aortic Endothelial Cells
J. Biol. Chem., January 9, 2004; 279(2): 963 - 969.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
H. Negishi, J.-W. Xu, K. Ikeda, M. Njelekela, Y. Nara, and Y. Yamori
Black and Green Tea Polyphenols Attenuate Blood Pressure Increases in Stroke-Prone Spontaneously Hypertensive Rats
J. Nutr., January 1, 2004; 134(1): 38 - 42.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. K. Roberts, N. D. Vaziri, R. K. Sindhu, and R. J. Barnard
A high-fat, refined-carbohydrate diet affects renal NO synthase protein expression and salt sensitivity
J Appl Physiol, March 1, 2003; 94(3): 941 - 946.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. S. Gragasin, Y. Xu, I. A. Arenas, N. Kainth, and S. T. Davidge
Estrogen Reduces Angiotensin II-Induced Nitric Oxide Synthase and NAD(P)H Oxidase Expression in Endothelial Cells
Arterioscler Thromb Vasc Biol, January 1, 2003; 23(1): 38 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Chen, L. Cao, H. D. Intengan, M. Humphreys, and D. G. Gardner
Osmoregulation of Endothelial Nitric-oxide Synthase Gene Expression in Inner Medullary Collecting Duct Cells. ROLE IN ACTIVATION OF THE TYPE A NATRIURETIC PEPTIDE RECEPTOR
J. Biol. Chem., August 30, 2002; 277(36): 32498 - 32504.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Kagota, A. Tamashiro, Y. Yamaguchi, K. Nakamura, and M. Kunitomo
High Salt Intake Impairs Vascular Nitric Oxide/Cyclic Guanosine Monophosphate System in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 344 - 351.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. DENG, N. D. VAZIRI, B. JABBARI, Z. NI, and X.-X. YAN
Increased Tyrosine Nitration of the Brain in Chronic Renal Insufficiency: Reversal by Antioxidant Therapy and Angiotensin-Converting Enzyme Inhibition
J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1892 - 1899.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. D. Vaziri, Y. Ding, and Z. Ni
Compensatory Up-Regulation of Nitric-Oxide Synthase Isoforms in Lead-Induced Hypertension; Reversal by a Superoxide Dismutase-Mimetic Drug
J. Pharmacol. Exp. Ther., August 1, 2001; 298(2): 679 - 685.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. Govers and T. J. Rabelink
Cellular regulation of endothelial nitric oxide synthase
Am J Physiol Renal Physiol, February 1, 2001; 280(2): F193 - F206.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. D. Vaziri and Y. Ding
Effect of Lead on Nitric Oxide Synthase Expression in Coronary Endothelial Cells : Role of Superoxide
Hypertension, February 1, 2001; 37(2): 223 - 226.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. D. Vaziri, Z. Ni, F. Oveisi, and D. L. Trnavsky-Hobbs
Effect of Antioxidant Therapy on Blood Pressure and NO Synthase Expression in Hypertensive Rats
Hypertension, December 1, 2000; 36(6): 957 - 964.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. K. Roberts, N. D. Vaziri, X. Q. Wang, and R. J. Barnard
Enhanced NO Inactivation and Hypertension Induced by a High-Fat, Refined-Carbohydrate Diet
Hypertension, September 1, 2000; 36(3): 423 - 429.
[Abstract] [Full Text] [PDF]